Guyana vs Yemen: Average cost of multi drug-resistant tuberculosis treatment
Guyana
2,586 constant 2022 US$
in 2024
Yemen
2,510 constant 2022 US$
in 2024
Guyana rank
19th
Yemen rank
20th
Average cost of multi drug-resistant tuberculosis treatment over time
- Guyana
- Yemen
How they compare
Guyana currently reports 2,586 constant 2022 US$ against 2,510 constant 2022 US$ in Yemen, a difference of 76 constant 2022 US$.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Yemen ahead.
Guyana ranks 19th and Yemen ranks 20th of 92 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guyana | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,450 constant 2022 US$ | 2,790 constant 2022 US$ | 1,340 constant 2022 US$ | Yemen |
| 2020s | 1,812 constant 2022 US$ | 3,052 constant 2022 US$ | 1,241 constant 2022 US$ | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Guyana or Yemen?
- Guyana, at 2,586 constant 2022 US$ against 2,510 constant 2022 US$ in Yemen as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Guyana and Yemen?
- 76 constant 2022 US$, with Guyana ahead.
- How many years of comparable data are there for Guyana and Yemen?
- 6 years are reported by both, from 2017 to 2024.
- How do Guyana and Yemen rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Guyana ranks 19th and Yemen ranks 20th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.